Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2026-05-27 @ 9:46 PM
Study NCT ID:
NCT05053035
Status:
TERMINATED
Last Update Posted:
2025-06-18
First Post:
2021-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Sponsor:
Alector Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis | View |
Keywords: